PFIZER/ALZA EXTENDED-RELEASE GLIPIZIDE (GLUCOTROL XL) MARKETING
Executive Summary
PFIZER/ALZA EXTENDED-RELEASE GLIPIZIDE (GLUCOTROL XL) MARKETING will begin "immediately" through Pfizer's Pratt Pharmaceuticals Division. Pfizer announced the approval of the anti-diabetes product on April 28 at its annum meeting, two days after FDA clearance and less than two weeks prior to the expiration of Pfizer's exclusive marketing protection for the standard-release dosage form of glipizide (Glucotrol). Worldwide sales of Glucotrol were $63.5 mil. (up 18%) in 1993.